Hype or hope? The developing evidence base for psychedelic treatment of addiction disorders.
The British journal of psychiatry : the journal of mental science March 21, 2025 DOI: 10.1192/bjp.2025.19 via PubMed
Summary
AI-generated from the abstractRecent interest and investment in psychedelic compounds for addiction disorders is growing. Evidence from randomized trials suggests therapeutic potential, though more research is needed. The editorial outlines future research directions and discusses implications for patients, healthcare professionals, and the broader addiction treatment system.
Study at a glance
| Characteristics | Editorial Randomized Peer reviewed |
|---|---|
| Keywords | Psychedelic Addictions Clinical trials Evidence-based mental health Substance use disorders |
| Citations | 1 |
| Key finding | Evidence from randomized trials suggests psychedelic compounds have therapeutic potential for addiction disorders, but more research is needed. |
Abstract
There has been substantial recent renewed interest and investment to assess the therapeutic potential of psychedelic compounds in addiction disorders. This editorial discusses the available evidence from randomised trials and future research directions in the field, together with potential implications for patients, professionals and the wider addiction treatment system.